Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor cell-derived N-acetyl-aspartyl-glutamate reshapes the tumor microenvironment to facilitate breast cancer metastasis.
Xia J, Zhang L, Zhu W, Tu J, Peng X, Deng Q, Li S, He X, Dong H, Liu C, Chen X, Xu J, Ma W, Xiao Y, Liu W, Hu G, Jiang YZ, Chen C, Bian XW, Shao ZM, Liu S. Xia J, et al. Among authors: jiang yz. Sci Bull (Beijing). 2024 Dec 27:S2095-9273(24)00949-6. doi: 10.1016/j.scib.2024.12.039. Online ahead of print. Sci Bull (Beijing). 2024. PMID: 39800628
Dietary methionine supplementation promotes mice hematopoiesis after irradiation.
Zhang WW, Xiang Y, Chen L, Liu ST, Lin CC, Li JX, Xiang LX, Chen NX, Shi DL, Zhang YY, Wang XY, Hu LY, Chen S, Luo Y, Tan CN, Xue PP, Jiang YZ, Li SC, Yang ZX, Dai JG, Li ZJ, Ran Q. Zhang WW, et al. Among authors: jiang yz. Mil Med Res. 2024 Dec 20;11(1):83. doi: 10.1186/s40779-024-00584-x. Mil Med Res. 2024. PMID: 39702305 Free PMC article.
Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple-Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1-Regulated Cholesterol Metabolism.
Yang Y, Liao J, Pan Z, Meng J, Zhang L, Shi W, Wang X, Zhang X, Zhou Z, Luo J, Chen X, Yang Z, Mei X, Ma J, Zhang Z, Jiang YZ, Shao ZM, Chen FX, Yu X, Guo X. Yang Y, et al. Among authors: jiang yz. Adv Sci (Weinh). 2024 Dec 10:e2413103. doi: 10.1002/advs.202413103. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 39656925
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
He M, Jiang YZ, Gong Y, Fan L, Liu XY, Liu Y, Tang LC, Mo M, Hou YF, Di GH, Liu GY, Yu KD, Wu J, Yan X, Zeng XH, Fu DY, Song CG, Zhuang ZG, Wu KJ, Wang J, Wang ZH, Shao ZM. He M, et al. Among authors: jiang yz. BMJ. 2024 Oct 23;387:e079603. doi: 10.1136/bmj-2024-079603. BMJ. 2024. PMID: 39442958 Free PMC article. Clinical Trial.
455 results